IL217261A0 - Hyr1 as a target for active and passive immunization against candida - Google Patents

Hyr1 as a target for active and passive immunization against candida

Info

Publication number
IL217261A0
IL217261A0 IL217261A IL21726111A IL217261A0 IL 217261 A0 IL217261 A0 IL 217261A0 IL 217261 A IL217261 A IL 217261A IL 21726111 A IL21726111 A IL 21726111A IL 217261 A0 IL217261 A0 IL 217261A0
Authority
IL
Israel
Prior art keywords
hyr1
target
active
passive immunization
immunization against
Prior art date
Application number
IL217261A
Other languages
English (en)
Original Assignee
Los Angeles Biomed Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Angeles Biomed Res Inst filed Critical Los Angeles Biomed Res Inst
Publication of IL217261A0 publication Critical patent/IL217261A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Passenger Equipment (AREA)
IL217261A 2009-07-03 2011-12-28 Hyr1 as a target for active and passive immunization against candida IL217261A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22300509P 2009-07-03 2009-07-03
PCT/US2010/040949 WO2011003085A1 (en) 2009-07-03 2010-07-02 Hyr1 as a target for active and passive immunization against candida

Publications (1)

Publication Number Publication Date
IL217261A0 true IL217261A0 (en) 2012-02-29

Family

ID=43411487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL217261A IL217261A0 (en) 2009-07-03 2011-12-28 Hyr1 as a target for active and passive immunization against candida

Country Status (15)

Country Link
US (2) US8709446B2 (https=)
EP (1) EP2448959B1 (https=)
JP (2) JP5690822B2 (https=)
KR (1) KR20120085234A (https=)
CN (1) CN102574895B (https=)
AU (2) AU2010266114B2 (https=)
BR (1) BR112012000036A2 (https=)
CA (1) CA2766805A1 (https=)
ES (1) ES2606555T3 (https=)
IL (1) IL217261A0 (https=)
MX (1) MX2012000018A (https=)
NZ (1) NZ597442A (https=)
RU (2) RU2559537C2 (https=)
SG (1) SG177456A1 (https=)
WO (1) WO2011003085A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
WO2011003085A1 (en) 2009-07-03 2011-01-06 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Hyr1 as a target for active and passive immunization against candida
GEP201706766B (en) 2011-07-22 2017-10-25 Los Angeles Biomedical Res Center Methods and compositions for vaccinating against staphylococcus aureus
BR112014005773A2 (pt) * 2011-09-14 2019-09-24 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center composições derivadas de hyr1 e métodos of tratamento usando as mesmas
WO2014144024A1 (en) * 2013-03-15 2014-09-18 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Hyr1 compositions and methods for treating fungal and bacterial pathogens
US10130691B2 (en) 2013-03-15 2018-11-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
GB201306588D0 (en) 2013-04-11 2013-05-29 King S College London Peptides and Binding Partners Therefor
EP3426287A4 (en) 2016-03-09 2020-03-11 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Methods and kits for use in preventing and treating vulvovaginal candidiasis
CN113508176A (zh) 2019-02-28 2021-10-15 米尼翁大学 用于控制白色念珠菌感染的反义寡聚物
CN110229221B (zh) * 2019-06-27 2022-04-12 上海交通大学医学院附属仁济医院 一种用于检测侵袭性白色念珠菌病的抗原及其用途
US20220354935A1 (en) * 2021-04-21 2022-11-10 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Vaccination against fungal epitopes to prevent inflammatory bowel diseases
WO2025248488A1 (en) * 2024-05-29 2025-12-04 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Compositions and methods for preventing and treating healthcare-associated candida auris infections with dual antigen vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031998A1 (en) 1994-05-23 1995-11-30 The Research & Development Institute, Inc. Candida albicans adhesin as a vaccine
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
US20070077256A1 (en) * 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US20060083750A1 (en) * 1999-11-19 2006-04-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
US6734344B2 (en) * 1999-12-10 2004-05-11 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agrifood Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1
US7241613B1 (en) * 2002-06-05 2007-07-10 Oscient Pharmaceuticals Corporation Identification of Candida cell surface proteins and their uses
RU2316595C1 (ru) * 2006-06-16 2008-02-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Способ получения антимикробного пептида ареницина
WO2011003085A1 (en) 2009-07-03 2011-01-06 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Hyr1 as a target for active and passive immunization against candida

Also Published As

Publication number Publication date
KR20120085234A (ko) 2012-07-31
EP2448959B1 (en) 2016-09-07
AU2016244238A1 (en) 2016-10-27
EP2448959A4 (en) 2013-01-02
AU2010266114B2 (en) 2016-07-14
RU2012103502A (ru) 2013-08-10
SG177456A1 (en) 2012-02-28
RU2015122387A (ru) 2015-10-27
US8709446B2 (en) 2014-04-29
MX2012000018A (es) 2012-03-29
NZ597442A (en) 2014-01-31
CN102574895B (zh) 2014-06-11
WO2011003085A1 (en) 2011-01-06
JP2015120722A (ja) 2015-07-02
ES2606555T3 (es) 2017-03-24
BR112012000036A2 (pt) 2018-04-03
RU2015122387A3 (https=) 2019-01-28
RU2559537C2 (ru) 2015-08-10
WO2011003085A9 (en) 2011-07-28
CA2766805A1 (en) 2011-01-06
CN102574895A (zh) 2012-07-11
JP5690822B2 (ja) 2015-03-25
JP2012532114A (ja) 2012-12-13
US20140335114A1 (en) 2014-11-13
EP2448959A1 (en) 2012-05-09
AU2010266114A1 (en) 2012-02-02
US20120237534A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
IL217261A0 (en) Hyr1 as a target for active and passive immunization against candida
ZA201204260B (en) Tracking method
GB2472783B (en) Device for manufacturing titanium objects
GB201117683D0 (en) Tracking system and method
SG10201402270WA (en) A biodegradable ocular implant
PL2475872T3 (pl) Fundament dla wieży turbiny wiatrowej
IL218022A0 (en) Corneal inlay with nutrient transport structures
IL215935A0 (en) Combined plant
EP2490621A4 (en) SYSTEM AND METHOD FOR OCULAR IMPLANT
EP2531674A4 (en) TOWER CONSTRUCTION AND ITS ERECTION METHOD
IL197996A (en) A method for locating people
PL2794865T3 (pl) Laktonaza pochodząca od Candida Bombicola i jej zastosowania
GB201018557D0 (en) Method & apparatus -seal-less valve
GB201010180D0 (en) Tracking method
GB0814068D0 (en) Active immunisation against GIP
EP2588030A4 (en) Convex concave implant
HU1000254V0 (en) Cannula and cannula - stucture for implanting
IL209700A0 (en) Implant locator
TWI367316B (en) Sun tracking method
EP2592086A4 (en) TELOMERASE INHIBITORS AND PROCESS FOR THEIR PRODUCTION
IL201055A0 (en) Fuel evaporation system and method
GB0920002D0 (en) A plant and a method
PL389194A1 (pl) Środek gryzoniobójczy
IL208530A0 (en) A system and method for tracking missiles
IL207884A0 (en) A tracking system and method